Skip to content

Xilio Therapeutics, Inc.: filings

Every Xilio Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 20 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-12fiscal Q2 2026391100001193125-26-345759
10-Q2026-05-12fiscal Q1 202639830001193125-26-218200
10-K2026-03-23fiscal FY 202545890001193125-26-118550
10-Q2025-11-13fiscal Q3 2025401110001193125-25-278837
10-Q2025-08-14fiscal Q2 2025391080001558370-25-011477
10-Q2025-05-08fiscal Q1 202540800001558370-25-006996
10-K2025-03-11fiscal FY 202444870001558370-25-002640
10-Q2024-11-07fiscal Q3 2024401080001558370-24-014775
10-Q2024-08-08fiscal Q2 2024401090001558370-24-011471
10-Q2024-05-14fiscal Q1 202440820001558370-24-008068
10-K2024-04-01fiscal FY 202344880001558370-24-004530
10-Q2023-11-09fiscal Q3 2023401140001558370-23-018587
10-Q2023-08-14fiscal Q2 2023401110001558370-23-014711
10-Q2023-05-09fiscal Q1 202340850001558370-23-008676
10-K2023-03-02fiscal FY 202245900001558370-23-002687
10-Q2022-11-09fiscal Q3 2022411170001558370-22-017018
10-Q2022-08-09fiscal Q2 2022411130001558370-22-012756
10-Q2022-05-12fiscal Q1 202240850001558370-22-008441
10-K2022-03-01fiscal FY 202144890001558370-22-002552
10-Q2021-12-02fiscal Q3 2021391100001558370-21-016476

Inspect the source

Entity
Xilio Therapeutics, Inc. / CIK 0001840233
Captured
2026-09-21T17:30:01.125Z
SEC response SHA-256
b9926482eefa7db7b34c666b313bfea22c6dec41b8b13a61f284b5e4d27a2eaa

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001840233.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))